Antagonizing apolipoprotein J chaperone promotes proteasomal degradation of mTOR and relieves hepatic lipid deposition.
Shuangdi DuanNong QinJiayi PiPei SunYating GaoLamei LiuZenghui LiYa LiLiyang ShiQiang GaoYe QiuSongqing TangChun-Hsiang WangTzu-Ying ChenSin-Tian WangKung-Chia YoungHung-Yu SunPublished in: Hepatology (Baltimore, Md.) (2023)
ApoJ antagonist peptide might be a potential therapeutic against lipid-associated metabolic disorders through restoring mTOR and FBW7 interaction and facilitating ubiquitin-proteasomal degradation of mTOR.